Archives of Psychiatric Nursing
Volume 24, Issue 2 , Pages 114-124 , April 2010

Challenging Normative Orthodoxies in Depression: Huxley's Utopia or Dante's Inferno?

  • John R. Cutcliffe

      Affiliations

    • Corresponding Author InformationCorresponding Author: John R. Cutcliffe, Bsc (Hon) Nrsg, PhD, RMN, RGN, RN, RPN, Professor of Nursing, College of Nursing and Health Sciences, Tyler, TX 75799.
    • ,
  • Richard Lakeman

References 

  1. Antonuccio DO, Burns DD, Danton WG. Antidepressants: A triumph of marketing over science?. Prevention & Treatment. 2002;Article 25 5(1):http://www.journals.apa.org/prevention/volume5/pre0050025c.html(retrieved 2008)
  2. Balon R. Selective serotonin reuptake inhibitors and suicide: Is the evidence, as with beauty, in the eye of the beholder?. Psychotherapy and Psychosomatics. 2003;72:292–299
  3. Barrkman H. The Prozac revolution. http://www.wej.com.au/newmoon/features/prozac/prozac.html2008;
  4. Bell-Dolan DJ, Reaven NM, Peterson L. Depression and social functioning: A multidimensional study of linkages. Journal of Clinical Child Psychology. 1993;22:306–315
  5. Breggin P. Toxic psychiatry—drugs and electroconvulsive therapy: The truth and the better alternatives. London: Harper Collins; 1994;
  6. Breggin PR. Reclaiming our children. Cambridge, MA: Peresus Books; 2000;
  7. British Broadcasting Corporation . Secret of the drug trends. http://news.bbc.co.uk/2/hi/programmes/panorama/16291773.stm2009;
  8. Campbell P. Book review: Coming off psychiatric drugs: Successful withdrawal from neuroleptics, antidepressants, lithium, carbamazepine and tranquilizers. Mental Health Practice. 2005;8(7):33
  9. Cassano P, Fava M. Depression and public health: An overview. Journal of Psychosomatic Research. 2002;53(4):849–857
  10. Chamberlin J. Prefaces. In:  Lehman P editors. Coming off psychiatric drugs: Successful withdrawal from neuroleptics, antidepressants, lithium, carbamazepine and tranquilizers. Shrewsbury, UK: Peter Lehman Publishing; 2004;p. 1–2
  11. Craft LL, Landers DM. The effect of exercise on clinical depression: A meta-analysis. Medicine Sports Science Exercise. 1998;30(Supplement, 5):S117
  12. Currie J. The marketization of depression: The prescribing of SSRI antidepressants to women. Women and Health Protection. 2005;http://www.whp-apsf.ca/pdf/SSRIs.pdf
  13. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Archives of General Psychiatry. 2005;62:409–416
  14. Ener R, Meglathery S, VanDecker SW, et al. Serotonin syndrome and other serotonergic disorders. Pain Medicine. 2003;4(1):63–74
  15. Godlee F. Reputations for sale?. http://news.bbc.co.uk/2/hi/programmes/panorama/6298269.stm2008;
  16. Goldney R. Risk factors for suicidal behaviour. In:  Hawton K editors. Prevention and treatment of suicidal behaviour: From science to practice. Oxford: Oxford University Press; 2005;p. 161–182
  17. Gregorian R, Golden K, Bache A, et al. Anti-depressant induced sexual dysfunction. Annals of Pharmacotherapy. 2002;36:1577–1589
  18. Haddad PM. Antidepressant discontinuation syndrome: Clinical prevalence, prevention and management. Drug Safety. 2001;24(3):183–197
  19. Healthcare Commission . Community mental health services—views of mental health service users: Key findings from the 2007 survey. London: Healthcare Commission; 2007;
  20. Healy D. Lines of evidence on the risk of suicide with selective serotonin reuptake inhibitors. Psychotherapy and Psychosomatics. 2003;72:71–76
  21. Hemels M, Koren G, Einarson T. Increased use of antidepressants in Canada: 1981–2000. Annals of Pharmacotherapy. 2002;36:1375–1379
  22. Hollon SD, DeRubeis RJ, Shelton R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Archives of General Psychiatry. 2005;2005:417–422
  23. IMS Canada . Retail prescriptions grow at record level in 2003. http://www.imshealthcanada.com/vgn/images/portal/cit_40000873/0/37/78325962retail_prescriptions_grow_record_level.pdf2008;
  24. Kahn A, Kahn SR, Leventhal RM, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: An analysis of the Food and Drug Administration database. International Journal of Neuropsychopharmacology. 2001;4:113–118
  25. Kahn A, Warner HA, Brown WA. Symptom reduction and suicide risk in patients treated with placebo in anti-depressant drug trials: An analysis of the Food and Administration database. Archives of General Psychiatry. 2000;57:311–317
  26. Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. Journal of Psychosomatic Research. 2002;53(4):859–863
  27. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine. 2008;5(2):e45
  28. Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The emperor's new drugs: an analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration. Prevention and Treatment. 2002;5. article 23. Available: http://www.journals.apa.org/prevention/volume5/pre0050023a.html(retrieved 2008)
  29. Kripke D. Light treatment for non-seasonal depression: Speed, efficacy, and combined treatment. Journal of Affective Disorders. 1998;49(2):109–117
  30. Lahti P. Prefaces. In:  Lehman P editors. Coming off psychiatric drugs: Successful withdrawal from neuroleptics, antidepressants, lithium, carbamazepine and tranquilizers. Shrewsbury, UK: Peter Lehman Publishing; 2004;p. 2–3
  31. Laurance J. Antidepressant drugs don't work—official study. Independent. 2008, February 26;
  32. Lehman P. Coming off psychiatric drugs: Successful withdrawal from neuroleptics, antidepressants, lithium, carbamazepine and tranquilizers. Shrewsbury, UK: Peter Lehman Publishing; 2004;
  33. Maio HA. Do-it-yourself withdrawal. Ragged Edge Online. 2008;http://www.ragged-edge-mag.com/reviews/maiolehmann.html
  34. Maltsberger J. cited in Maris, R. W., Berman, A. L., Silverman, M. M. (2000) Comprehensive textbook of suicidology. New York: Guildford Press; 1992;
  35. Maris RW, Berman AL, Silverman MM. Comprehensive textbook of suicidology. New York: Guildford Press; 2000;
  36. Medawar C, Hardon A. Medicines out of control?—antidepressants and the Conspiracy of goodwill. Amsterdam: Aksant Academic Publishers; 2004;
  37. MIND . MIND news, policy and campaigns—MIND releases latest drugs report Coping With Coming Off. http://www.mind.org.uk/News+policy+and+campaigns/Press+archive/CWCO0905.htm2008;
  38. Moncrieff J, Hopker S, Thomas P. Psychiatry and the pharmaceutical industry: Who pays the piper?. Psychiatric Bulletin. 2005;29:84–85
  39. Moncrieff J, Kirsch I. Efficacy of antidepressants in adults. British Medical Journal. 2006;331:155–157
  40. Moncrieff J, Wessely S, Hardy R. Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry. 1998;172:227–231
  41. Moore T. Prescription for disaster. New York: Dell Publishing; 1998;
  42. Mosher L. Soteria and other alternatives to acute psychiatric hospitalization: A personal and professional review. Journal of Nervous and Mental Disease. 1999;187:142–149
  43. Mosher L. Non-hospital, non-drug intervention with first-episode psychosis. In:  Read L,  Mosher LR,  Bentall RP editor. Models of madness. London: Routledge; 2004;p. 349–364
  44. Munoz-Arroyo R, Sutton M, Morrison J. Exploring potential explanations for the increase in antidepressant prescribing in Scotland using secondary analyses of routine data. British Journal of General Practice. 2006;56(527):423–428
  45. National Institute for Health and Clinical Excellence . Quick reference guide—amended—depression: Management of depression in primary and secondary care. London: National Institute for Health and Clinical Excellence; 2007;
  46. National Institute for Mental Health . Results for Sequenced Treatment Alternatives to Relieve Depression (STAR⁎D) study. http://www.nimh.nih.gov/science-news/2007/in-second-try-to-treat-depression-cognitive-therapy-generally-as-effective-as-medication.shtml2008;
  47. North TC, McCullagh P, Tran ZV. Effect of exercise on depression. Exercise Sports Science Review. 1990;18:379–415
  48. Paluska SA, Schwenk TL. Physical activity and mental health: Current concepts. Sports Medicine. 2000;29(3):167–180
  49. Service User Research Enterprise . Service user priorities for research. London: Institute of Psychiatry/Kings College; 2007;
  50. Sharfstein SS. Presidential address: Advocacy as leadership. American Journal of Psychiatry. 2006;163:1711–1715
  51. Smale R. Peering through the darkness: The subjective experience of clinical depression. Journal of Psychiatric and Mental Health Nursing. 2000;7:277–283
  52. Stevens L. The myth of biological depression. www.antipsychiatry.org2007;
  53. Storosum JG, Van Zwieten BJ, Van den Brink W, Gersons BPP, Broekmans AW. Suicide risk in placebo-controlled studies of major depression. American Journal of Psychiatry. 2001;158:1271–1275
  54. Styron W. Darkness visible. London: Cape Publishing; 1991;
  55. Szasz T. The myth of mental illness: Foundations of a theory of personal conduct. New York: Harper Collins; 1961;
  56. Szasz T. The medicalisation of everyday life—selected essays. Syracuse, NY: Syracuse University Press; 2007;
  57. Thase ME, et al. Cognitive therapy as a second-step treatment: A STAR⁎D report. American Journal of Psychiatry. 2007;164:
  58. United States Food and Drug Administration. (2004) Worsening depression and suicidality of patients being treated with anti-depressant medications Public Health Advisory March 22.
  59. Van Praag H. Why haven't antidepressants reduced suicide rates?. In:  Hawton K editors. Prevention and treatment of suicidal behaviour: From science to practice. Oxford: Oxford University Press; 2005;p. 239–260
  60. Van Praag HM. Stress and suicide: Are we well-equipped to study this issue?. Crisis: The Journal of Crisis Intervention and Suicide Prevention. 2004;25(2):8–85
  61. Walcraft J. The mental health service user movement in England. London: The Sainsbury Centre for Mental Health; 2003;
  62. Westgate CE. Spiritual wellness and depression. Journal of Counselling and Development. 1996;75(1):26–35
  63. World Health Organization . Mental health—depression. http://www.who.int/mental_health/management/depression/definition/en/2008;
  64. Young AH, Haddad P. Discontinuation symptoms and psychotropic drugs. Lancet. 2000;355(9210):correspondence

 This article was based on a presentation the first author was invited to deliver at the 29th Congress of the International Academy of Law and Mental Health held in Paris 2005.

PII: S0883-9417(09)00088-0

doi: 10.1016/j.apnu.2009.06.004

Archives of Psychiatric Nursing
Volume 24, Issue 2 , Pages 114-124 , April 2010

Article Tools